Trial: 202012127

A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections with Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients – NYMC 580

Phase

II

Principal Investigator

Shenoy, Shalini

Disease Site

Other Hematopoietic

Learn more about this study at: clinicaltrials.gov